CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade LifeMD, Inc. - LFMD CFD

    8.01
    1.6%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.07
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026346 %
    Charges from full value of position ($-5.01)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026346%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004124 %
    Charges from full value of position ($0.78)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004124%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 8.14
    Open* 8.13
    1-Year Change* 215.12%
    Day's Range* 7.89 - 8.22
    52 wk Range 1.14-7.77
    Average Volume (10 days) 719.19K
    Average Volume (3 months) 12.45M
    Market Cap 265.85M
    P/E Ratio -100.00K
    Shares Outstanding 37.98M
    Revenue 135.81M
    EPS -0.99
    Dividend (Yield %) N/A
    Beta 1.46
    Next Earnings Date Mar 20, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 4, 2023 8.14 0.50 6.54% 7.64 8.17 7.64
    Dec 1, 2023 7.72 0.06 0.78% 7.66 8.15 7.51
    Nov 30, 2023 7.66 0.28 3.79% 7.38 7.90 7.38
    Nov 29, 2023 7.14 0.25 3.63% 6.89 7.54 6.89
    Nov 28, 2023 6.84 0.05 0.74% 6.79 7.03 6.77
    Nov 27, 2023 6.89 0.29 4.39% 6.60 6.95 6.60
    Nov 24, 2023 6.65 -0.11 -1.63% 6.76 6.91 6.61
    Nov 22, 2023 6.85 -0.12 -1.72% 6.97 7.02 6.81
    Nov 21, 2023 6.95 -0.03 -0.43% 6.98 7.10 6.81
    Nov 20, 2023 7.06 -0.11 -1.53% 7.17 7.26 6.89
    Nov 17, 2023 7.17 -0.05 -0.69% 7.22 7.49 7.17
    Nov 16, 2023 7.38 0.01 0.14% 7.37 7.64 7.27
    Nov 15, 2023 7.47 0.32 4.48% 7.15 7.57 7.10
    Nov 14, 2023 7.19 0.07 0.98% 7.12 7.61 7.09
    Nov 13, 2023 7.05 0.26 3.83% 6.79 7.06 6.50
    Nov 10, 2023 6.85 0.12 1.78% 6.73 6.89 6.61
    Nov 9, 2023 6.77 -0.50 -6.88% 7.27 7.36 6.17
    Nov 8, 2023 7.12 -0.05 -0.70% 7.17 7.49 7.00
    Nov 7, 2023 7.16 0.12 1.70% 7.04 7.72 7.04
    Nov 6, 2023 7.28 0.25 3.56% 7.03 7.33 6.86

    LifeMD, Inc. Events

    Time (UTC) Country Event
    Wednesday, December 6, 2023

    Time (UTC)

    10:59

    Country

    US

    Event

    LifeMD Inc at Sidoti & Company December Virtual Small-Cap Conference
    LifeMD Inc at Sidoti & Company December Virtual Small-Cap Conference

    Forecast

    -

    Previous

    -
    Wednesday, March 20, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q4 2023 LifeMD Inc Earnings Release
    Q4 2023 LifeMD Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 119.034 92.8758 37.2939 12.4686 8.32413
    Revenue 119.034 92.8758 37.2939 12.4686 8.32413
    Cost of Revenue, Total 18.668 17.9954 8.86119 3.2706 1.96906
    Gross Profit 100.365 74.8804 28.4327 9.19798 6.35507
    Total Operating Expense 162.418 151.172 96.0282 15.3582 10.3803
    Selling/General/Admin. Expenses, Total 130.364 124.951 84.7288 11.1404 8.41121
    Research & Development 2.9702 0.77877 0.44675 0.22288
    Operating Income -43.3844 -58.2966 -58.7343 -2.88961 -2.05614
    Interest Income (Expense), Net Non-Operating -1.27595 -3.01972 -1.66754 -0.76115 -0.35439
    Net Income Before Taxes -44.6603 -61.3164 -60.4019 -3.65076 -2.41053
    Net Income After Taxes -45.021 -61.3241 -60.5243 -3.52826 -2.28583
    Minority Interest -0.51463 0.42635 1.87741 0.39106 0.11926
    Net Income Before Extra. Items -45.5357 -60.8977 -58.6469 -3.1372 -2.16657
    Net Income -45.5357 -60.8977 -58.6469 -3.1372 -1.24083
    Income Available to Common Excl. Extra. Items -48.6419 -61.7692 -63.363 -3.1372 -2.16657
    Income Available to Common Incl. Extra. Items -48.6419 -61.7692 -63.363 -3.1372 -1.24083
    Diluted Net Income -48.6419 -61.7692 -63.363 -3.1372 -1.24083
    Diluted Weighted Average Shares 30.9765 27.008 14.2752 9.89775 8.83748
    Diluted EPS Excluding Extraordinary Items -1.57029 -2.28707 -4.43869 -0.31696 -0.24516
    Diluted Normalized EPS -1.38565 -2.19091 -4.39703 -0.31696 -0.24516
    Unusual Expense (Income) 8.7992 3.99556 0.91486 0
    Total Extraordinary Items 0 0.92574
    Other Operating Expenses, Total 1.6168 3.4522 1.07666 0.72427
    Total Adjustments to Net Income -3.10625 -0.87148 -4.71602
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 35.9469 33.1263 28.1197 31.4125 30.4585
    Revenue 35.9469 33.1263 28.1197 31.4125 30.4585
    Cost of Revenue, Total 4.54843 4.21497 4.0677 4.71684 4.63531
    Gross Profit 31.3985 28.9114 24.052 26.6956 25.8232
    Total Operating Expense 40.8425 36.3043 36.0037 38.2302 46.0342
    Selling/General/Admin. Expenses, Total 33.8055 29.0988 27.977 31.166 36.2763
    Research & Development 1.38069 1.1836 1.01916 0.82164 0.70107
    Unusual Expense (Income) 0 0.3252 6.1276 0 2.6716
    Other Operating Expenses, Total 1.10779 1.48177 -3.18783 1.52565 1.74997
    Operating Income -4.89555 -3.178 -7.88394 -6.8177 -15.5757
    Interest Income (Expense), Net Non-Operating -0.99567 -0.26447 -0.84354 -0.13224 -0.13224
    Net Income Before Taxes -5.89122 -3.44247 -11.2145 -7.19794 -12.973
    Net Income After Taxes -5.89122 -3.44247 -11.5752 -7.19794 -12.973
    Minority Interest -0.84178 -0.56598 -0.36017 -0.08374 -0.046
    Net Income Before Extra. Items -6.733 -4.00846 -11.9354 -7.28167 -13.019
    Net Income -6.733 -4.00846 -11.9354 -7.28167 -13.019
    Total Adjustments to Net Income -0.77656 -0.77656 -0.77656 -0.77656 -0.77656
    Income Available to Common Excl. Extra. Items -7.50956 -4.78502 -12.7119 -8.05824 -13.7955
    Income Available to Common Incl. Extra. Items -7.50956 -4.78502 -12.7119 -8.05824 -13.7955
    Diluted Net Income -7.50956 -4.78502 -12.7119 -8.05824 -13.7955
    Diluted Weighted Average Shares 32.56 31.6808 31.4142 30.9356 30.8045
    Diluted EPS Excluding Extraordinary Items -0.23064 -0.15104 -0.40465 -0.26048 -0.44784
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.23064 -0.14077 -0.27787 -0.26048 -0.36111
    Other, Net 0 -2.487 -0.248 2.735
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 11.3114 44.9214 12.4127 2.7471 1.60507
    Cash and Short Term Investments 3.95896 41.328 9.17908 1.10662 0.18009
    Cash 3.95896 41.328 9.17908 1.10662 0.18009
    Total Receivables, Net 2.83475 0.98006 0.99776 0.09745 0.09905
    Accounts Receivable - Trade, Net 2.83475 0.98006 0.99776 0.09745 0.09905
    Total Inventory 3.70336 1.6166 1.26426 0.95006 1.02262
    Total Assets 25.6658 49.9232 13.403 3.44618 2.61614
    Total Current Liabilities 31.3741 22.8256 13.9324 3.97544 1.1924
    Payable/Accrued 12.1434 3.05116 0.869
    Notes Payable/Short Term Debt 2.79725 0.0634 0.77913 0.81473 0.24742
    Other Current Liabilities, Total 8.21635 4.45619 0.91688 0.10955 0.07598
    Total Liabilities 32.4958 23.0724 12.0491 4.43436 1.71844
    Total Long Term Debt 0 0 0 0 0
    Minority Interest -0.47555 -1.03175 -2.17569 -0.14106 -0.07796
    Total Equity -6.82996 26.8509 1.35392 -0.98819 0.8977
    Common Stock 0.31553 0.30705 0.23434 0.53404 0.45782
    Additional Paid-In Capital 179.015 164.518 77.7794 15.2364 12.7443
    Retained Earnings (Accumulated Deficit) -190.563 -141.921 -80.1519 -16.5949 -12.1407
    Treasury Stock - Common -0.1637 -0.1637 -0.1637 -0.1637 -0.1637
    Total Liabilities & Shareholders’ Equity 25.6658 49.9232 13.403 3.44618 2.61614
    Total Common Shares Outstanding 31.4497 30.6014 23.3306 10.5777 9.05342
    Other Current Assets, Total 0.81429 0.99675 0.97164 0.59297 0.30331
    Intangibles, Net 12.6721 3.01555 0.71582 0.67545 1.01107
    Deferred Income Tax 0.07 0.004
    Other Liabilities, Total 1.59721 1.27854 0.29232 0.52998 0.6
    Property/Plant/Equipment, Total - Net 1.68245 1.98625 0.27444 0.02363
    Accrued Expenses 10.2538 9.24679 0.093
    Redeemable Preferred Stock 43.5435 39.9805 3.6575
    Preferred Stock - Non Redeemable, Net -38.9775 -35.8695 -0.00168
    Accounts Payable 10.1068 9.05921
    Total Preferred Shares Outstanding 1.4 1.4
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 24.8863 20.1809 19.1648 11.3114 12.9737
    Cash and Short Term Investments 15.2883 11.9067 11.5248 3.95896 5.83682
    Cash 15.2883 11.9067 11.5248 3.95896 5.83682
    Total Receivables, Net 4.41858 3.66854 2.937 2.83475 2.53812
    Accounts Receivable - Trade, Net 4.41858 3.66854 2.937 2.83475 2.53812
    Total Inventory 3.79065 3.6983 3.38258 3.70336 3.67613
    Other Current Assets, Total 1.38873 0.90731 1.32034 0.81429 0.92263
    Total Assets 40.691 35.4464 33.8698 25.6658 33.3616
    Property/Plant/Equipment, Total - Net 1.22374 1.37292 1.57724 1.68245 1.82281
    Intangibles, Net 14.581 13.8926 13.1278 12.6721 12.9104
    Total Current Liabilities 32.5219 31.5178 27.0186 31.3741 24.9353
    Payable/Accrued
    Notes Payable/Short Term Debt 0.42622 0.73553 1.82249 2.79725 0
    Other Current Liabilities, Total 9.02061 9.21038 8.68855 8.21635 4.76975
    Total Liabilities 53.3622 46.435 41.1993 32.4958 29.4789
    Total Long Term Debt 18.8273 13.5385 13.4231 0 0
    Minority Interest 1.58691 0.78362 -0.0315 -0.47555 -0.79972
    Other Liabilities, Total 0.42607 0.59509 0.78911 1.59721 5.34333
    Total Equity -12.6712 -10.9886 -7.32951 -6.82996 3.88266
    Redeemable Preferred Stock 41.216 45.549 44.4255 43.5435 42.63
    Common Stock 0.34759 0.32565 0.3204 0.31553 0.31458
    Additional Paid-In Capital 196.901 186.674 183.184 179.015 177.132
    Retained Earnings (Accumulated Deficit) -209.757 -202.858 -195.348 -190.563 -177.851
    Treasury Stock - Common -0.1637 -0.1637 -0.1637 -0.1637 -0.1637
    Total Liabilities & Shareholders’ Equity 40.691 35.4464 33.8698 25.6658 33.3616
    Total Common Shares Outstanding 34.6562 32.4618 31.937 31.4497 31.3547
    Long Term Debt 18.8273 13.5385 13.4231
    Accounts Payable 9.63739 9.59338 6.90303 10.1068 10.7975
    Accrued Expenses 13.4377 11.9785 9.60454 10.2538 9.36799
    Goodwill, Net 5.65467
    Total Preferred Shares Outstanding 1.4 1.4 1.4 1.4 1.4
    Preferred Stock - Non Redeemable, Net -41.2159 -40.5159 -39.7473 -38.9775 -38.1787
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -45.021 -61.3241 -60.5243 -3.52826 -1.36009
    Cash From Operating Activities -22.9352 -33.0855 -12.1316 0.25141 -0.90552
    Cash From Operating Activities 0.16189 0.01356
    Deferred Taxes 0.354
    Non-Cash Items 18.6222 18.2376 39.1978 1.37782 0.51477
    Cash Interest Paid 0.189 0.43505 1.66517 0.08066 0.00438
    Changes in Working Capital -0.66055 9.13218 8.79717 2.06623 -0.25597
    Cash From Financing Activities -0.5282 68.6367 21.0022 0.77512 0.80279
    Financing Cash Flow Items -0.2881 -0.444 -0.17222 -0.37316 0.15627
    Issuance (Retirement) of Stock, Net 0.1289 70.483 21.0812 0.35 0.00408
    Issuance (Retirement) of Debt, Net 2.73725 -0.53082 0.09319 0.79828 0.64244
    Net Change in Cash -37.3691 32.149 8.07245 0.92653 0.03871
    Amortization 3.60835 0.8552 0.39777 0.33561 0.19578
    Cash From Investing Activities -13.9057 -3.40229 -0.79814 -0.1 0.14145
    Capital Expenditures -8.89284 -3.38006 -0.39814 0 -0.1
    Other Investing Cash Flow Items, Total -5.0129 -0.02223 -0.4 -0.1 0.24145
    Total Cash Dividends Paid -3.10625 -0.87148
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -3.44247 -45.021 -33.4459 -26.2479 -13.275
    Cash From Operating Activities -2.61394 -22.9352 -20.9661 -18.1901 -8.09114
    Amortization 1.32221 3.60835 2.41368 1.31731 0.49821
    Non-Cash Items 2.69767 18.6222 13.4865 8.87612 4.59131
    Cash Interest Paid 0.273 0.189 0 0 0
    Changes in Working Capital -3.23899 -0.66055 -3.53749 -2.20888 0.06182
    Cash From Investing Activities -1.81164 -13.9057 -12.1347 -9.89315 -7.37819
    Capital Expenditures -1.81164 -8.89284 -7.12182 -4.88026 -2.36529
    Other Investing Cash Flow Items, Total 0 -5.0129 -5.0129 -5.0129 -5.0129
    Cash From Financing Activities 11.9915 -0.5282 -2.39039 -1.52748 -0.77406
    Financing Cash Flow Items -0.40501 -0.2881 -0.1896 -0.10325 -0.036
    Issuance (Retirement) of Stock, Net 0 0.1289 0.1289 0.1289 0.0385
    Issuance (Retirement) of Debt, Net 13.173 2.73725 0 0
    Net Change in Cash 7.56589 -37.3691 -35.4912 -29.6107 -16.2434
    Cash From Operating Activities 0.04765 0.16189 0.11701 0.07325 0.03248
    Total Cash Dividends Paid -0.77656 -3.10625 -2.32969 -1.55313 -0.77656
    Deferred Taxes 0.354
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Schreiber (Justin) Individual Investor 7.2472 2611371 50000 2023-05-23 LOW
    Divisadero Street Capital Management, LP Investment Advisor/Hedge Fund 5.319 1916592 1916592 2023-10-04 HIGH
    Galluppi (Stefan) Individual Investor 4.5993 1657249 4608 2023-05-23 LOW
    Royce Investment Partners Investment Advisor/Hedge Fund 2.831 1020082 -50000 2023-06-30 LOW
    Velge (Bertrand) Individual Investor 2.5884 932666 123000 2023-04-24 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.029 731113 22978 2023-06-30 LOW
    Bhatia (Naveen) Individual Investor 1.3525 487349 225000 2023-06-14 HIGH
    EAM Investors, LLC Investment Advisor/Hedge Fund 1.3225 476528 476528 2023-06-30 HIGH
    B. Riley Financial, Inc Investment Advisor 1.2872 463823 -458222 2023-06-30 LOW
    Febbo (William J) Individual Investor 1.2489 450000 450000 2023-06-20 LOW
    Strawn (John R Jr.) Individual Investor 1.0833 390347 50000 2023-08-25
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.0563 380596 4763 2023-06-30 LOW
    American Financial Group, Inc. Insurance Company 0.9436 340000 0 2023-06-30 LOW
    Granahan Investment Management, Inc. Investment Advisor 0.8492 305993 89490 2023-06-30 LOW
    Jindal (Piyush) Individual Investor 0.7285 262500 225000 2023-06-14 HIGH
    Roberts (Brad Michael) Individual Investor 0.6734 242632 150000 2023-06-13 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.6315 227554 28687 2023-06-30 LOW
    Benathen (Marc David) Individual Investor 0.6204 223564 150000 2023-07-11 HIGH
    Alvarez (Nicholas P) Individual Investor 0.6125 220712 150000 2023-07-12 HIGH
    Yecies (Eric Harold) Individual Investor 0.5967 215000 161500 2023-06-15 HIGH

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    LifeMD, Inc. Company profile

    LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men''s sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men''s telehealth brand that offers virtual medical treatment from licensed providers for a variety of men''s health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York.
    Industry: Medical Software & Technology Services

    236 Fifth Avenue
    Suite 400
    NEW YORK
    NEW YORK 10001
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    BTC/USD

    43,497.00 Price
    +3.950% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    XRP/USD

    0.62 Price
    -0.200% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Oil - Crude

    72.56 Price
    -1.150% 1D Chg, %
    Long position overnight fee -0.0224%
    Short position overnight fee 0.0005%
    Overnight fee time 22:00 (UTC)
    Spread 0.040

    Gold

    2,019.23 Price
    -0.460% 1D Chg, %
    Long position overnight fee -0.0200%
    Short position overnight fee 0.0118%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading